AURA Aura Biosciences Inc
Price (delayed)
$5.38
Market cap
$270.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.75
Enterprise value
$257.29M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet
Highlights
Aura Biosciences's EPS has increased by 9% YoY
AURA's debt is down by 4% YoY
AURA's quick ratio is down by 45% YoY and by 15% from the previous quarter
AURA's equity is down by 33% year-on-year and by 13% since the previous quarter
Key stats
What are the main financial stats of AURA
Market
Valuations
Earnings
Shares outstanding
50.23M
Market cap
$270.21M
Enterprise value
$257.29M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.77
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$96.12M
Net income
-$86.92M
EBIT
-$86.81M
EBITDA
-$84.11M
Free cash flow
-$81.06M
Per share
Balance sheet
Liquidity
EPS
-$1.75
EPS diluted
-$1.75
Free cash flow per share
-$1.63
Book value per share
$3.04
Revenue per share
$0
TBVPS
$3.68
Total assets
$182.5M
Total liabilities
$30.53M
Debt
$18.77M
Equity
$151.97M
Working capital
$145.71M
Debt to equity
0.12
Current ratio
10.77
Quick ratio
10.13
Net debt/EBITDA
0.15
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-41.3%
Return on equity
-47.8%
Return on invested capital
-46%
Return on capital employed
-51.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AURA stock price
How has the Aura Biosciences stock price performed over time
Intraday
-2.54%
1 week
0.37%
1 month
-24.01%
1 year
-24.01%
YTD
-34.55%
QTD
-8.19%
Financial performance
How have Aura Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$96.12M
Net income
-$86.92M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 14% YoY and by 4.4% QoQ
AURA's operating income is down by 13% year-on-year and by 3.3% since the previous quarter
Growth
What is Aura Biosciences's growth rate over time
Valuation
What is Aura Biosciences stock price valuation
P/E
N/A
P/B
1.77
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aura Biosciences's EPS has increased by 9% YoY
AURA's equity is down by 33% year-on-year and by 13% since the previous quarter
AURA's price to book (P/B) is 23% less than its last 4 quarters average of 2.3
Efficiency
How efficient is Aura Biosciences business performance
Aura Biosciences's return on equity has decreased by 15% QoQ and by 13% YoY
AURA's return on invested capital is down by 14% since the previous quarter and by 4.3% year-on-year
The return on assets has declined by 13% since the previous quarter and by 13% year-on-year
Dividends
What is AURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AURA.
Financial health
How did Aura Biosciences financials performed over time
AURA's quick ratio is down by 45% YoY and by 15% from the previous quarter
AURA's current ratio is down by 43% year-on-year and by 14% since the previous quarter
AURA's debt is 88% less than its equity
The debt to equity is up by 33% year-on-year and by 9% since the previous quarter
AURA's equity is down by 33% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.